All Industries

Top Diagnostics Companies

116 Diagnostics companies, sorted by total funding raised.

Owlstone Medical

Cambridge UK biotech developing Breath Biopsy platform for early disease detection using volatile...

Cambridge, United Kingdom51–200Healthcare, Diagnostics
Series E·$100.0M·Jan 2025
Variantyx

Molecular diagnostics lab providing whole-genome-based genetic testing for rare disorders, reprod...

Boston, United States51–200Diagnostics, Genomics
Series D·$100.0M·Apr 2024
Xilis

Develops MicroOrganoSphere ex vivo tumor models and AI analytics to guide precision oncology and ...

Durham, United States51–200Biotech, Diagnostics
Series A·$92.0M·Apr 2025
QuanterixIPO

Develops ultrasensitive biomarker detection instruments and assays for researchers, pharmaceutica...

Billerica, United States201–500Diagnostics, Healthcare
Series D·$85.5M·Mar 2016
American Pathology PartnersAcquired

Leading provider of anatomic pathology and prognostic/diagnostic testing services to physician of...

Nashville, United StatesDiagnostics, Healthcare
Venture Round·$75.0M·Apr 2008
BAEBIES, INC.

R&D company with 44 SBIR/STTR awards from Department of Health and Human Services, Department of ...

DURHAM, United States51–200Biotech, Diagnostics
Series C·$62.6M·Jan 2022
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Series A·$58.5M·Nov 2011
VeracyteIPO

Veracyte is a global cancer diagnostics company that provides genomic tests to help clinicians di...

South San Francisco, United States501–1000Biotech, Diagnostics
Series C·$56.3M·Jun 2013
Dr. Lal PathLabsIPO

India's top diagnostics chain

New Delhi, India1001–5000Healthcare, Diagnostics
Venture Round·$53.6M·Feb 2013
Aria DiagnosticsAcquired

Non-invasive prenatal diagnostic testing company

San Jose, United StatesHealthcare, Diagnostics
Series C·$52.7M·Jan 2012
Lucira HealthAcquired

Next generation infectious disease test kits

Emeryville, United States11–50Diagnostics, Healthcare
Series B·$52.0M·Aug 2019
Spear Bio

Develops ultra-sensitive homogeneous immunoassay kits and services for biomarker research and cli...

Boston, United States11–50Biotech, Diagnostics
Series A·$45.0M·Jul 2024
YourBio HealthAcquired

Develops TAP devices using bladeless microneedle HALO technology for virtually painless capillary...

Medford, United States11–50Diagnostics, Healthcare
Venture Round·$41.0M·Sep 2021
HeartVista

HeartVista is a medical technology company that provides one-click diagnostic imaging. Healthcare...

San Francisco Bay Area, United States11–50Diagnostics, Healthcare
Series B·$38.1M·Jan 2026
Orange Health Labs

India's Fastest Diagnostics Service

Bengaluru, India1–10Diagnostics, Digital Health
Growth Equity·$37.0M·Dec 2024
SynapDxClosed

Developer of blood-based diagnostic tests for early detection of autism spectrum disorders using ...

Lexington, United States1–10Biotech, Diagnostics
Venture Round·$35.2M
AOA Dx

Blood Test for Early Detection of Ovarian Cancer

11–50Diagnostics, Femtech
Venture Round·$34.8M·Oct 2025
Sollis Health

Concierge medical care platform offering 24/7 emergency and primary care membership services.

New York, United States201–500Healthcare, Diagnostics
Venture Round·$33.0M·Dec 2024
Scout (formerly Uh-Oh Labs)

The smart testing platform that unlocks digital health at home.

11–50Diagnostics, Digital Health
Grant·$30.4M·Oct 2022
Function Oncology

Develops a CRISPR-powered personalized functional genomics platform to profile patient tumors and...

San Diego, United States1–10Biotech, Diagnostics
Series A·$28.0M·Apr 2023
Sera PrognosticsIPO

Precision biomarker-based diagnostics company improving pregnancy outcomes through the PreTRM tes...

Salt Lake City, United States51–200Biotech, Diagnostics
Series A·$19.3M·Feb 2011
Evvy

At-home vaginal microbiome testing and care platform offering metagenomic sequencing, clinician-r...

San Francisco, United States11–50Life Sciences, Biotech
Series A·$19.0M·Sep 2023
D
DiatideAcquired

Therapeutic peptides and imaging agents for thrombus, atherosclerosis and inflammation

Londonderry, United StatesBiotech, Diagnostics
Venture Round·$18.7M
Cofactor Genomics

Cofactor closes the precision medicine gap with predictive diagnostics

St. Louis, United States11–50Biotech, Diagnostics
Series A·$18.0M·Sep 2017
SimpleHealthkit

Provides end-to-end digital health platform delivering at-home and in-clinic diagnostics, follow-...

Fremont, United States11–50Healthcare, Digital Health
Series A·$16.0M·Feb 2023